Relaxation of human isolated pulmonary arteries by prostacyclin (PGI2).
D000328:Adult; D000368:Aged; D015237:Dinoprost; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D011464:Epoprostenol / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects*; D009126:Muscle Relaxation / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D011460:Prostaglandins F / Q000494:pharmacology; D011651:Pulmonary Artery / Q000187:drug effects*; D014655:Vascular Resistance / Q000187:drug effects
D011453:Prostaglandins; D011460:Prostaglandins F; D015237:Dinoprost; D011464:Epoprostenol; D011188:Potassium; D009638:Norepinephrine; D007213:Indomethacin